Zena Chahine

Zena Chahine, MD, is an Assistant Professor in the Division of Hematology, Blood and Marrow Transplantation and Cellular Therapy Program at the University of Kentucky's Department of Internal Medicine. Her work focuses on hematologic malignancies, particularly acute myeloid leukemia (AML), multiple myeloma, and lymphoma, with an emphasis on treatment outcomes, genetic mutations, and disparities in care.

Her research integrates clinical studies with molecular analysis to explore the impact of therapies like allogeneic stem cell transplantation and CAR T-cell therapy on patient outcomes. She also investigates the influence of social determinants of health and regional variations on cancer treatment efficacy.

Recent publications highlight her contributions to understanding AML's genetic and clinical differences in obese patients, the role of hypomethylating agents in transplant preparation, and the interplay between molecular mutations and survival. Her work employs AI for risk stratification and examines case studies involving rare hematologic disorders.